BMSCs |
miR-210-3p, miR-193a-3p, and miR-5100 |
Exosome-mediated transfer of miRNAs activates STAT3 pathway |
Enhanced cancer cell invasion and EMT |
[86] |
Melanoma |
RAB1A, RAB5B, RAB7, and RAB27A |
Reprogrammed cells were positive for c-Kit, receptor tyrosine kinase Tie2, and Met |
Increased metastatic behavior, induced vascular leakiness at pre-metastatic sites, and reprogrammed bone marrow progenitor cells |
[53] |
Tumor |
snRNAs |
Activation of lung epithelial TLR3 to recruit neutrophils |
TLR3-deficient mice showed reduced lung metastasis |
[49] |
Phosphorylation of NF-κB p65 subunit and MAPKs ERK, JNK, and p38 signaling pathway |
Exosomal snRNAs activated TLR3 to induce chemokine secretion and neutrophil recruitment |
hucMSCs |
– |
Activation of Smad2/3, AKT/GSK-3β/β-catenin, NF-κB, ERK, JNK, and p38 MAPK in TGF-β1 signaling pathways |
Promoted EMT, invasion, and migration, yet inhibited proliferation and promoted apoptosis of lung cancer cells |
[84] |
Lung tumor |
circSATB2 |
Positive regulation of FSCN1 expression via miR-326 in lung cancer cells |
Enhanced proliferation, migration, and invasion of NSCLC cells, as well as an induced abnormal proliferation of normal human bronchial epithelial cells |
[66] |
Lung tumor |
miR-660-5p |
miR-660-5p targeting of KLF9 to promote tumorigenesis |
Enhanced proliferation, migration, viability, and metastasis |
[67] |
Lung tumor |
circ-CPA4 and let-7 miRNA |
CPA4-regulated effects via let-7 miRNA/PD-L1 axis |
Promoted cell stemness, mobility, and drug resistance of NSCLC |
[68] |
Lung tumor |
lnc-MMP2-2 |
TGF-β-mediated exosomal miRNA regulation |
Increased cancer cell migration, invasion potential, and vascular permeability |
[69] |
Mouse and human lung tumor |
integrins α6β4 and α6β1 |
Activation of Src phosphorylation and pro-inflammatory S100 gene expression |
Associated with lung metastasis and predict organ-specific metastasis |
[50] |
SCLC patients and mouse model |
miR-141 |
Activation of miR-141/KLF12 pathway |
SCLC angiogenesis |
[42] |
Administration of lung cancer-derived exosomes to NIH/3T3 cells |
miR-210 |
Modulation of JAK2/STAT3 signaling pathway and TET2 in recipient fibroblasts |
Increased angiogenesis via elevated expression of proangiogenic factors MMP9, FGF2 and VEGFA |
[43] |
NSCLC cells |
miR-619-5p |
Targeted inhibition of RCAN1.4 |
Promoted growth and metastasis of NSCLCs |
[73] |
Adipocytes |
MMP3 and MMP9 |
Transfer of MMP3 to activate MMP9 |
Promoted lung tumor metastasis |
[85] |
Plasma |
Three clusters of miRNAs including miR-574-5p, 328-3p and miR-423-3p |
Regulation of the Wnt/β-catenin pathway |
Involved in preconditioning the metastatic niche and promoting bone metastasis of lung cancer |
[78] |